Skip to main content

Advertisement

Log in

Langerhans cell histiocytosis presenting as a rapidly evolving frontotemporal syndrome

  • Brief Communication
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Langerhans cell histiocytosis (LCH) is a rare disorder in adults which usually manifests with involvement of multiple organ systems, including the central nervous system. We describe an unusual case of biopsy-proven LCH presenting with frontotemporal-dominant cognitive impairment with hypothalamic involvement, along with multisystem disease. We propose that the dementia was probably an immune-mediated process triggered by LCH which responded dramatically to high-dose steroids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Emile JF, Abla O, Fraitag S et al (2016) Histiocyte Society. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127(22):2672–2681

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Allen CE, Li L, Peters TL et al (2010) Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared to epidermal Langerhans cells. J Immunol Baltim Md 1950 184(8):4557–4567

    CAS  Google Scholar 

  3. Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F (1997) Langerhans’-cell histiocytosis in adults. Med Pediatr Oncol 28(1):9–14

    Article  CAS  PubMed  Google Scholar 

  4. Grana N (2014 Oct 1) Langerhans cell histiocytosis. Cancer Control 21(4):328–334

    Article  PubMed  Google Scholar 

  5. Grois N, Pötschger U, Prosch H, Minkov M, Arico M, Braier J, Henter JI, Janka-Schaub G, Ladisch S, Ritter J, Steiner M, Unger E, Gadner H, for the DALHX- and LCH I and II Study Committee (2006) Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer 46(2):228–233

    Article  CAS  PubMed  Google Scholar 

  6. Gallo MSG, Martínez MP, Abalovich MS et al (2010) Endocrine manifestations of Langerhans cell histiocytosis diagnosed in adults. Pituitary 13(4):298–303

    Article  CAS  Google Scholar 

  7. Grois N, Prayer D, Prosch H, CNS LCH Co-operative Group et al (2005) Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 128:829–838

    Article  PubMed  Google Scholar 

  8. Allen CE, Flores R, Rauch R, Dauser R, Murray JC, Puccetti D, Hsu DA, Sondel P, Hetherington M, Goldman S, McClain KL (2010) Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus: treated with vincristine/cytosine Arabinoside. Pediatr Blood Cancer 54(3):416–423

    Article  PubMed  PubMed Central  Google Scholar 

  9. Tamai S, Ueno M, Hayashi Y et al (2018) Enlargement of Langerhans cell histiocytosis of the hypothalamus with progression into the basal ganglia and white matter. Surg Neurol Int 9:197

    Article  PubMed  PubMed Central  Google Scholar 

  10. Yeh EA, Greenberg J, Abla O et al (2018) Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: current views and new vistas. Pediatr Blood Cancer 65(1). https://doi.org/10.1002/pbc.26784

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rajesh Kumar Singh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garg, D., Pedapati, R., Nakra, T. et al. Langerhans cell histiocytosis presenting as a rapidly evolving frontotemporal syndrome. Neurol Sci 40, 1055–1058 (2019). https://doi.org/10.1007/s10072-019-3709-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-019-3709-y

Keywords

Navigation